Submental Area Treatment with ATX-101: Relationship of Mechanism of Action, Tissue Response, and Efficacy
Background:. ATX-101 is an injectable, synthetically derived formulation of deoxycholic acid used for submental fat reduction. Methods:. A narrative review of references relevant to the mechanism of action of ATX-101 and its relationship to efficacy and inflammatory adverse events was conducted. Res...
Main Authors: | Shannon Humphrey, MD, FRCPC, FAAD, Girish S. Munavalli, MD, MHS, FACMS, Steven G. Yoelin, MD, Daniel P. Friedmann, MD, FAAD, Carmen M. Kavali, MD, Sara Sangha, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-04-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004250 |
Similar Items
-
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
by: Craig F. Teller, MD, et al.
Published: (2021-07-01) -
Alopecia after injection of ATX-101 for reduction of submental fat
by: Skylar Souyoul, MD, et al.
Published: (2017-05-01) -
Abstract: Alopecia in Male Patients Treated with ATX-101 (Deoxycholic Acid) for Submental Fullness
by: Sachin M. Shridharani, MD, et al.
Published: (2017-09-01) -
Abstract: Novel Expanded Safe Zone System for Treatment of Submental Fullness with ATX-101 (Deoxycholic Acid)
by: Sachin M. Shridharani, MD, et al.
Published: (2017-09-01) -
Abstract: Injection Adipocytolysis with ATX-101 (Deoxycholic Acid) for Body Contouring
by: Sachin M. Shridharani, MD, et al.
Published: (2017-09-01)